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Introduction
Cardiac myocyte gap junctions are large specialized aggregates of 
intercellular channels responsible for cell-to-cell communication. 
Their role is essential for propagation of electrical activity that is 
required for cardiac function. Cardiac gap junction channels are 
formed by connexins, each of which imparts distinct biophysical 
properties depending on the connexin subtype.1-4 Three of the five 
connexins expressed in cardiac myocytes are found in ventricular 
myocardium. Of those three, Cx43 is the predominant connexin 
expressed in working ventricular myocytes and is responsible for 
electrical propagation throughout the chamber walls.5 The other 
Gap junction channels in ventricular myocardium are required for electrical and metabolic coupling between cardiac 
myocytes and for normal cardiac pump function. Although much is known about expression patterns and remodeling 
of cardiac connexin (Cx)43, little is known about the less abundant Cx45, which is required for embryonic development 
and viability, is downregulated in adult hearts, and is pathophysiologically upregulated in human end-stage heart 
failure. We applied quantitative immunoblotting and immunoprecipitation to native myocardial extracts, immunogold 
electron microscopy to cardiac tissue and membrane sections, electrophysiological recordings to whole hearts, and 
high-resolution tandem mass spectrometry to Cx45 fusion protein, and developed two new tools, anti-Cx45 antisera and 
Cre+;Cx45 floxed mice, to facilitate characterization of Cx45 in adult mammalian hearts.
We found that Cx45 represents 0.3% of total Cx protein (predominantly 200 fmol Cx43 protein/μg ventricular protein) 
and colocalizes with Cx43 in native ventricular gap junctions, particularly in the apex and septum. Cre+;Cx45 floxed mice 
express 85% less Cx45, but do not exhibit overt electrophysiologic abnormalities. Although the basal phosphorylation 
status of native Cx45 remains unknown, CaMKII phosphorylates eight Ser/Thr residues in Cx45 in vitro.
Thus, although downregulation of Cx45 does not produce notable deficits in electrical conduction in adult, disease-
free hearts, Cx45 is a target of the multifunctional kinase CaMKII, and the phosphorylation status of Cx45 and the role of 
Cx43/Cx45 heteromeric gap junction channels in both normal and diseased hearts merits further investigation.
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two, Cx45 and Cx30.2, are expressed primarily in the cardiac 
conduction system;6,7 however, the human ortholog, Cx31.9, is 
not expressed in the human cardiac conduction system.8 Cx40 is 
expressed in the atria.9-11 Most recently, Gros et al.12 have shown 
that Cx30 is expressed in the mouse sino-atrial (SA) node. Of 
note, Cx45 is absolutely required for cardiac development; genetic 
ablation of Cx45 is embryonic lethal.13,14 It is the only connexin 
protein whose absence during embryonic development is incom-
patible with life. Nevertheless, it appears that Cx45 may not be at 
all necessary for normal cardiac function post-natally.
As stated above, Cx45 is localized at the endocardial surface 
of ventricular myocardium15 in a distribution overlapping that of 
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Absolute expression levels of Cx45 and Cx43 in native mouse 
ventricular myocardium. Quantitative immunoblots were per-
formed by loading different amounts of six His-Cx45 CT and 
GST-Cx43 CT fusion proteins along with samples of ventricu-
lar homogenates (Fig. 1). The band densities of the ventricu-
lar homogenates fell within the linear portion of the standard 
curves for the fusion proteins. As expected, Cx43 protein levels 
far exceeded those of Cx45. Mean data from 16 hearts (Table 1) 
show that ventricular myocardium contained 215 ± 103 fmol of 
Cx43/μg protein. Our average protein yield from a larger group 
of 24 hearts was 127 ± 16 μg protein/mg wet weight of ventricu-
lar tissue, and the ventricles weighed 112 ± 15 mg wet weight 
(n = 24). Thus, based on these averages, we observed 27 pmol 
Cx43 protein per mg wet weight of tissue, and the ventricles of 
each heart expressed 3 nmol of Cx43. Cx45 protein expression 
in murine ventricular myocardium, on the other hand, was 0.7 
± 0.2 fmol/μg protein, or 10 pmol of Cx45 per heart, or 0.3% of 
total ventricular connexin protein levels (Table 1).
Relative expression of Cx45 and Cx43 in ventricular gap 
junctions. Despite the relatively low abundance of Cx45 in ven-
tricular myocardium, double label immunoelectron microscopy 
of vibratome sections of murine ventricular myocardium demon-
strated that Cx45- as well as Cx43-bound colloidal gold particles 
were found together in the same gap junction plaques (data not 
shown). All subsequent analyses were performed on gap junc-
tion-enriched membrane preparations (Fig. 2A). The majority 
(87%) of gap junctions isolated from WT hearts was labeled only 
with Cx43 (Fig. 2A, left and B). Double label immunoelectron 
microscopy of gap junction-enriched membrane fractions using 
a pre-embedding staining protocol showed more abundant label-
ing of Cx43 (96%) than Cx45 (4%) in plaques isolated from the 
13% of WT gap junctions that contained both Cx43 and Cx45 
(Fig. 2A, right and C). The combined Cx43 signal (87% plus 
0.96 of 13%, or 12.5% in heteromeric junctions) of 99.5% is 
consistent with the quantitative immunoblot data (99.7%).
Previously, we reported that Cx45OEs exhibit a 2-fold increase 
in Cx45 immunoreactive signal and a 25% increase in total Cx45 
protein on immunoblots.20 In the present study, we analyzed gap 
junction-enriched preparations isolated from WT and Cx45OE 
hearts. We found a larger percentage of heteromeric junctions 
(55% compared to 13% in wild-type hearts) in preparations iso-
lated from Cx45OE hearts (Fig. 2B). However, the relative stoi-
chiometry of Cx43:Cx45 was comparable in the 55% of Cx45OE 
gap junctions that contained both connexins; the relative abun-
dance of Cx43 and Cx45 in gap junctional plaques containing 
both Cx43 and Cx45 was ~95:5 in both WT and Cx45OE hearts 
(Fig. 2C). Of note, no gap junctions containing Cx45 alone were 
found in either genotype. Not surprisingly, there was more Cx45 
staining as a percentage of total Cx43 plus Cx45 found in prepa-
rations isolated from Cx45OE (4.1%) compared to WT hearts 
(1.4%). Finally, the percentage of heteromeric gap junctions 
containing both Cx43 and Cx45 was higher in gap junction-
enriched membrane preparations isolated from the LV apex plus 
septum compared to those isolated from the LV free wall, con-
sistent with more Cx45 expressed in the ventricular conduction 
system (Fig. 2D).
Cx40-expressing myocytes of the conduction system. Expression 
of Cx45 by adult working ventricular myocytes is limited.13,16 We 
have demonstrated that Cx45 is distributed throughout working 
ventricular myocardium of both adult murine and adult human 
hearts.17,18 Indeed, Cx45 is responsible for cell-to-cell coupling 
in Cx43-null myocytes.19 Because the expression level of Cx45 
relative to Cx43 is so much smaller, the contribution of Cx45 to 
intercellular current flow is thought to be minimal. However, we 
have shown that Cx45 is upregulated in human failing hearts,18 
and that increased expression of Cx45 enhances susceptibility to 
ventricular tachyarrhythmias in vivo.20 Thus, Cx45 may influ-
ence electrical and/or metabolic coupling as a result of patho-
physiological remodeling of gap junctions such as that observed 
after heart failure or myocardial infarction.
Cardiac connexins have been shown to interact and form het-
eromeric channels in vitro in heterologous expression systems.21-29 
Several studies have reported the consistent finding that expres-
sion of Cx45 (~29 pS channels) in cells expressing Cx43 (~90  pS 
channels) results in a dominant negative effect characterized by 
reduced gap junctional conductance and dye transfer.23-25 These 
observations suggest that the absolute abundance of different 
connexin proteins in gap junction channels and the relative stoi-
chiometry of multiple connexins within each channel in ven-
tricular myocytes are two important determinants of whole cell 
junctional conductances.
To date, Cx43/Cx45 heteromeric gap junction channels 
have not been identified definitively nor studied systematically 
in native ventricular myocytes. Although there is currently no 
direct evidence that Cx45/Cx43 heteromeric channels function 
in native hearts, the wide spectrum of single channel conduc-
tances observed in pairs of isolated cardiac myocytes,30-33 cou-
pled with the multitude of studies demonstrating heteromeric 
channel function in in vitro expression systems21-29,34-36 implicate 
the presence of Cx43/Cx45 heteromeric channels in the heart. 
The purpose of the present study was to determine the abso-
lute level of Cx45 protein relative to Cx43 in native ventricular 
myocardium from the adult mouse, and to establish whether 
Cx45 plays a role in cardiac conduction properties in non-fail-
ing hearts. We have obtained biochemical and ultra-structural 
evidence for coexistence of Cx43 and Cx45 in gap junctions of 
working ventricular myocytes. In addition, although the level 
of Cx45 protein expression was reduced by ~85% in cardiac-
restricted Cx45-deficient mice, no defects in cardiac conduction 
parameters were observed. Post-translational modification of 
Cx45, a potential regulatory mechanism for the expression and 
stability of Cx45, was also explored.
Results
Specificity of the monoclonal antibodies used for the quantitative 
immunoblots is shown in Figure 1 and Figure S3. Each antibody 
detected its respective CT fusion protein and connexin protein in 
ventricular samples, but not the other fusion protein or connexin 
in ventricular samples. The anti-Cx43 antibody detected either 
GST-Cx43 CT fusion protein (Fig. 1) or thrombin-cleaved Cx43 




In the present study, we created a line of mice with 
Cx45-deficient hearts (Fig. 4) in both our Bonn and St. Louis 
laboratories. Mice were not born with the expected Mendelian 
inheritance pattern, suggesting either transient embryonic activa-
tion of the α-MHC promoter or a survival advantage of perinatal 
expression of Cx45 protein. Only 9 Cre+;Cx45fl/fl mice were born 
out of 87 pups in 17 litters (Table 2). One mouse died before 
weaning; one mouse died after weaning but before it could be 
Co-precipitation of Cx43 and Cx45 from ventricular 
 myocardium. Ventricular lysates prepared from WT mice were 
subjected to immunoprecipitation. Immunoblotting with anti-
Cx45 antibody demonstrated that Cx45 was co-precipitated with 
proteins immunoprecipitated with anti-Cx43 antibody (Fig. 3). 
In addition, Cx43 was co-precipitated with proteins immunopre-
cipitated with anti-Cx45 antibody (Fig. 3).
Neither cardiac-restricted reduction nor overexpression of 
Cx45 significantly alters electrophysiological properties of the 
heart in vitro. Despite the overall low abundance of Cx45 in 
adult working ventricular myocytes, it is critical for development 
of the heart and vasculature.13,14 Mice with germline ablation of 
Cx45 die at embryonic day 10.5. Cx45 is present in the SA node 
and conduction system,7,15,46 where it can largely replace Cx40, 
producing normal propagation in the atrio-ventricular (AV) node 
and left bundle branch and partial loss of function in the right 
bundle branch as shown in transgenic mice in which Cx45 was 
engineered to replace Cx40.39 The question of whether Cx45 
plays any role in conduction has been difficult to assess in the 
absence of survival of mice with germline ablation of Cx45, and 
in the absence of suitable antibodies directed against Cx45.
Table 1. Concentration of Cx43 and Cx45 in ventricular myocardium
Per μg protein 
loaded on gel
Per mg wet weight 
of tissue




215 ± 103 fmol/μg 
protein





0.7 ± 0.2 fmol/μg 
protein
0.09 pmol/mg wet 
weight
10 pmol
Per tissue and per heart values were calculated using the following  
average empirical values obtained from 24 hearts: 127 μg protein/mg 
wet weight of ventricular tissue and 112 mg wet weight of RV + LV.
Figure 1. Representative quantitative immunoblots of a membrane probed first with anti-Cx45 antiserum (top), stripped, then reprobed with 
anti-Cx43 antibody (bottom). The gel was loaded with increasing amounts of Cx45 fusion protein (fp, five lanes on the left), ventricular homogenates 
from Cx45OE and wild-type (WT) mice (15 μg protein, four lanes in the middle), and increasing amounts of GST-Cx43 fusion protein (fp, five lanes on 
the right). The anti-Cx45 antiserum recognized only the Cx45 fusion protein at ~16 kD (top gel, left lanes) and Cx45 in the ventricular homogenates 
(top gel, center lanes), but not the Cx43 fusion protein (top gel, right lanes). The anti-Cx43 antibody, on the other hand, recognized only the GST-Cx43 
fusion protein at ~43 kD (bottom gel, right lanes) and Cx43 in the ventricular homogenates (bottom gel, center lanes), but not the Cx45 fusion protein 
(bottom gel, left lanes).
©2011 Landes Bioscience.
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Figure 2. Immunogold electron microscopy of cardiac connexins in hybrid (heteromeric and/or heterotypic) gap junctions. (A) Electron  micrographic 
images of gap junctions decorated with 10 nm gold particles conjugated with anti-Cx43 antiserum (left), and a gap junction containing a 20 nm 
gold particle conjugated to anti-Cx45 antiserum (inset, arrow) among numerous 10 nm gold particles conjugated to anti-Cx43 antibody (right). Bar 
= 100 nm. (B) Proportions of Cx43-bound gold particles and Cx45-bound gold particles as a percent of total gap junctions in gap junction-enriched 
membrane preparations isolated from wild-type (WT) and Cx45OE hearts. WT hearts exhibited a larger percentage (87%) of homomeric/ homotypic 
Cx43 gap junctions. In contrast, the percentages of Cx43 only and heteromeric gap junctions in Cx45OE hearts were roughly equivalent. Cx45 
 homomeric/homotypic gap junctions were not found in either WT or Cx45OE hearts. (C) The percentage of Cx43 and Cx45 in heteromeric gap 
 junction channels was comparable in WT and Cx45OE hearts, despite the fact that there was a greater proportion of heteromeric gap junction 
 channels in Cx45OE hearts. (D) Relative proportions of Cx43 homomeric/homotypic and Cx43/Cx45 heteromeric gap junctions by gross regions of the 
hearts. More heteromeric gap junctions were observed in the apex/septum compared to the LV free wall consistent with known expression of Cx45 in 
the cardiac conduction system which is concentrated in the subendocardial interventricular septum and in the distal Purkinje system.
Figure 3. Co-immunoprecipitation of Cx43 and Cx45 from murine ventricular myocardium. Cx45 (upper left, lane 5) or Cx43 (upper right, lane 3) were 
immunoprecipitated (IP) using mouse monoclonal anti-Cx45 or anti-Cx43 antibodies bound to protein G sepharose beads, respectively. The proteins 
in the immunoprecipitates were resolved by SDS-polyacrylamide gel electrophoresis and subjected to immunoblotting (IB) with rabbit polyclonal 
anti-Cx43 and anti-Cx45 antibodies to reveal Cx43 (square) in Cx45-associated proteins (lower left, lane 5) and Cx45 (square) in Cx43-associated 
proteins (lower right, lane 3). Neither Cx43 nor Cx45 were observed in the negative controls in which mouse IgG1 was bound to protein G sepharose 




Their surface ECGs appeared normal (data not shown). QRS 
complexes were comparable to those recorded from control mice 
(Fig. S4); QRS duration in cardiac Cx45-deficient mice was 11.2 
± 1.2 ms (n = 4, p = 0.367) compared to 10.5 ± 1.1 ms in FVB 
controls (n = 5). Mean ventricular effective refractory periods 
were 110 ms for cardiac Cx45-deficient hearts (n = 2) compared 
with 123 ± 19 ms for controls (n = 3). We measured activation 
times between the RV apex and the LV lateral free wall to assess 
conduction through the specialized conduction system compared 
with that through the ventricular myocardium. Conduction 
during sinus rhythm is expected to result in nearly simultane-
ous activation of the right and left ventricles; this was indeed 
observed as shown in Table S1; activation of right and left ven-
tricles occurred within 1 ms of each other, both in FVB controls 
(0.7 ± 1.2 ms) and in cardiac Cx45-deficient hearts (0.3 ms). 
Pacing from the right atrium produced similar activation times 
as those observed during sinus rhythm (0.6 ± 0.7 ms in controls 
vs. 1.0 ms in cardiac Cx45-deficient hearts). Pacing from the RV 
apex produced the expected activation delay through the ven-
tricular myocardium (12.5 ± 2.7 ms); a comparable mean delay 
(15.4 ms) was observed in the two cardiac Cx45-deficient hearts. 
studied. Of the seven remaining Cx45 cardiac-deficient mice, 
four mice were studied electrophysiologically. Immunoblotting 
(n = 6 Cx45-deficient mice) and immunostaining (n = 5 Cx45-
deficient mice) were performed using a new anti-Cx45 antiserum 
whose characterization is described in the Supplemental Material 
and Methods. As expected, Cx45 protein expression was reduced 
in Cx45-deficient hearts (Fig. 4B). Residual levels of Cx45 were 
still present in whole ventricular homogenates prepared from 
Cre+;Cx45fl/fl mice. Immunofluorescence images demonstrated an 
85% reduction in Cx45 immunoreactive signal in Cx45-deficient 
hearts compared to controls (Fig. 5, left parts). Using ImageJ, 
we quantified Cx45, Cx43 and Cx40 immunoreactive signal in 
ventricular myocardium and found that only Cx45 was reduced 
in Cx45-deficient hearts (Fig. 4C). Cx40 signal was analyzed in 
the conduction system located in the subendocardial region of 
the interventricular septum and was unchanged in cardiac Cx45-
deficient compared to control hearts (Fig. 4C).
Although cardiac Cx45-deficient mice were not born in the 
expected numbers, those that were born did not have any gross 
functional defects and survived to adulthood. Two Cre+;Cx45fl/fl 
mice gave birth to offspring that themselves grew to adulthood. 
Figure 4. Cardiac-restricted ablation of Cx45 was accomplished by crossing Cx45 floxed mice with α-MHC-Cre+ mice. (A) Agarose gel showing banding 
patterns of the PCR products used to genotype cardiac-restricted ablation of Cx45. DNA samples from 6 different mice were run on this gel. Two PCR 
reactions were run for each mouse to determine whether they carried the Cre transgene (lanes 1, 3, 5, 7, 9 and 11) and whether they carried two wild-
type, a wild-type and a floxed, or two floxed alleles (lanes 2, 4, 6, 8, 10 and 12). The sizes of the bands are as follows: Cx45 wild-type allele, 380 kb; Cx45 
floxed allele, 500 kb; Cre transgene, 292 kb. (B) Immunoblot of cardiac Cx45-deficient (Cre+;Cx45fl/fl) whole ventricular homogenates (F; lanes 2, 4 and 
6) and controls (C; lanes 1, 3 and 5) showing markedly reduced Cx45 in Cre+;Cx45fl/fl ventricles. Lane 7 shows a strong Cx45 band in atrial homogenate 
from Cx40KO/Cx45 knockin (KI) compared to the weaker Cx45 band in wild-type atrial homogenate (WT) shown in lane 8. The membrane was stripped 
and reprobed with anti-actin antibodies to show equal protein (20 μg) loading. (C) Histograms show summarized data of the confocal analysis of 
ventricular tissue sections stained with anti-Cx45, anti-Cx43 and anti-Cx40 antibodies. Values represent connexin immunoreactive signal as a percent 
of total tissue area (mean ± SD). Cx45 was significantly reduced in cardiac Cx45-deficient hearts. *p = 0.016.
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Because overall conduction velocities were not different in 
Cx45OEs, we quantified the spatial inhomogeneity in conduc-
tion by calculating an inhomogeneity index in a group of eight 
hearts (five wild-types and three Cx45OEs) from optical action 
potential data, as reported by Lammers et al.44 We paced each 
heart from the right atrium (n = 7) or high right septum (in one 
WT heart) at a basic cycle length of 180 ms. Activation times 
were obtained from optical action potentials collected from the 
LV lateral free wall. A small but significant increase in the inho-
mogeneity index of Cx45OE hearts was not accompanied by a 
difference in the absolute inhomogeneity of ventricular conduc-
tion in Cx45OE hearts (Table S4). Additional S1 or S1/S2 pacing 
protocols applied to the ventricles did not result in any significant 
differences in inhomogeneity indices between Cx45OE and WT 
hearts (data not shown). Thus, neither 85% reduction nor 2-fold 
overexpression of Cx45 significantly altered electrophysiological 
properties of the intact heart in vitro.
High-resolution identification of Ser phosphorylation 
sites on the Cx45 CT tail. The mechanism(s) responsible for 
controlling Cx45 protein expression levels are not known. 
Phosphorylation and/or dephosphorylation of Cx43 have/has 
been implicated in turnover of Cx43 after myocardial ischemic 
Although the number of mice studied was too low to perform 
statistical analyses, these data suggest that ablation of cardiac 
Cx45 does not adversely affect cardiac conduction. Isochronal 
maps demonstrating conduction in two cardiac Cx45-deficient 
hearts also indicate no difference in conduction velocity or pat-
terns compared to those in control hearts; one example is shown 
in Figure S5.
Previously, we found that Cx45OEs exhibited increased sus-
ceptibility to inducible ventricular arrhythmias compared to 
WT littermate controls.20 In the present study, we performed in 
vitro electrophysiology studies on perfused hearts. We calculated 
conduction velocities from optical action potentials elicited after 
S1 stimulation at the RV apex (180 ms cycle length) and after 
S2 stimulation at the center of the LV lateral free wall (140 ms 
coupling interval) in five Cx45OEs and six WT littermates. 
We found no significant differences in conduction velocities 
or anisotropic ratios recorded from Cx45OE versus WT hearts 
(Table S2). Ventricular activation times measured between the 
RV apex and the LV epicardial free wall were not different in 
Cx45OE compared to WT hearts (Table S3). Activation times 
obtained from these mice (C57BL6) were comparable to those 
obtained in mice in the FVB background (Table S1).
Figure 5. Representative confocal images from a control heart (upper three parts) and a Cre+;Cx45fl/fl heart (lower three parts) showing lack of Cx45 
staining in the ventricle of the cardiac-restricted Cx45-deficient heart (lower left part). Adjacent tissue sections were stained for Cx45, Cx43 and 
Cx40, and every effort was made to select the same region in each heart for comparison. The ventricular chamber is at the bottom of each field. The 
 subendocardial conduction system can be seen most clearly in the images stained for Cx40 (right parts). Cx43 and Cx45 are each expressed in this 
same region as well as in the ventricular myocardium beyond the subendocardial layer in the control heart (upper middle and left parts, respectively). 
Cx43 immunostaining is comparable in the control and Cre+;Cx45fl/fl hearts (upper and lower middle parts, respectively). Bars = 10 μm.
Table 2. Cardiac Cx45-deficient mice
No. of litters Mating No. of pups born Expected nulls (% of pups born) Actual nulls (% of pups born)
10 Cre-;Cx45fl/fl x Cre+;Cx45fl/+ 52 13 (25%) 3 (6%)
6 Cre-;Cx45fl/fl x Cre+;Cx45fl/fl 30 15 (50%) 5 (17%)
1 Cre+;Cx45fl/fl x Cre+;Cx45fl/+ 5 2.5 (50%) 1 (20%)




times more abundant than Cx45 (Table 1). Similar  expression 
levels of integral membrane proteins have been reported based 
on quantitative immunoblot analyses. McDonald et al. 50 reported 
70–80 fmol Na+-Ca2+ exchanger/μg protein in left and right ven-
tricles of guinea pig hearts. Valiunas et al.51 found 100–500 fmol 
Cx40 and Cx43/μg protein in HeLa cell transfectants. Recently, 
Lin et al.52 reported 400 fmol Cx43/μg protein in ventricular tis-
sue homogenates from neonatal mice.
Changes in Cx45 protein levels do not adversely affect car-
diac electrophysiological properties. The absence of measurable 
abnormal electrophysiological properties in cardiac Cx45-deficient 
and Cx45OE hearts is consistent with low levels of expression of 
Cx45 in tissue that has a large reserve of Cx43.53-56 It should be 
noted, however, that lack of a measurable defect does not prove 
absence of a defect in Cx45 transgenic mice. These studies do not 
address whether altered levels of Cx45 contribute to electrophysio-
logical abnormalities in diseased hearts or in those in which acute 
or chronic remodeling of Cx43 may have occurred due to aging, 
injury or other metabolic changes. In addition, closer examination 
of regions of the heart known to express Cx45 may reveal subtle 
functional differences when Cx45 is downregulated. For example, 
there are regions of the AV node in which Cx43 is significantly 
reduced or absent.57,58 Presumably, impulses propagate through 
Cx45 gap junction channels in this part of the AV junction and 
could be altered if expression of Cx45 is reduced. Similarly, regions 
of the SA node have been reported to express Cx45 alone (no 
Cx40 or Cx43),46 but both Cx30.2 and Cx30 are expressed in the 
SA node6,12 and may explain why we saw no sinus alterations in 
Cx45floxed mice. Finally, one area of interest that deserves greater 
scrutiny is the Purkinje system and Purkinje-myocyte junction. 
Recently, several elegant studies have highlighted the importance 
of the distal conduction system in triggering ventricular arrhyth-
mias.59 Our studies did not allow us to quantify properties of the 
distal conduction system at high enough resolution to rule out 
any defects in Purkinje fibers or their coupling with ventricular 
myocytes in Cx45-deficient hearts.
Post-translational modification of Cx45 by CaMKII. Our 
data demonstrating the existence of heteromeric gap junction 
channels in native ventricular myocardium combined with the 
observation that the ratio of Cx43:Cx45 not only regulates gap 
junctional intercellular communication,23-25,34-36 but gap junction 
size itself,17,60 suggest that the number and size of gap junctions in 
Cx45 transgenic hearts may be altered. The mechanisms underlying 
injury. Cx45 is known to be a phosphoprotein;47-49 however, it 
has not been studied as extensively as Cx43 with respect to phos-
phorylation at specific residues in the CT tail or with regard to 
specific protein kinases that may phosphorylate Cx45. In the 
present study, we subjected the six His-Cx45 CT fusion protein 
to phosphorylation by CaMKII and identified seven Ser (S326, 
S381, S382, S384, S385, S387, S393) and one Thr (T337) resi-
dues by high resolution mass spectrometry with 89% coverage 
of the Cx45 CT sequence (Fig. 6) that were targets of CaMKII 
in vitro. No phospho-peptides were identified in the negative 
control samples. Extracted ion chromatograms, MS1 and MS2 
spectra (Figs. S6–S10) and tables of theoretical and observed 
peptide fragmentation ions (Tables S5–S9) are included in the 
Supplemental Content for each phospho-peptide identified. 
Interestingly, five of the seven Ser residues that were phosphory-
lated by CaMKII were also found to be phosphorylated in vitro 
by CK1 (S326, S382, S384, S387, S393) as shown in Figures 
S11–S14 and Tables S10–S13.
Discussion
Residual Cx45 protein levels and heteromeric gap junctions in 
ventricular myocardium. Several studies have demonstrated that 
Cx45 is expressed in working ventricular myocardium and isolated 
myocytes.13,16-19 Although its protein level in normal, disease-free 
hearts is very low, the absolute amount of its protein expression 
had not been established. Furthermore, ultrastructural and bio-
chemical evidence of Cx43/Cx45 heteromeric gap junctions in 
native ventricular myocardium was lacking. In the present study, 
we have obtained evidence from immunogold electron micros-
copy as well as co-immunoprecipitation studies that supports the 
co-existence of Cx43 and Cx45 in native murine ventricular gap 
junctions. We used these two complementary approaches to dem-
onstrate presence of both Cx43 and Cx45 in cardiac gap junc-
tions. Immunogold labeling identified both Cx43 and Cx45 in 
individual gap junctions in intact sections in which cell and tis-
sue architecture were preserved. Immunolabeling of membrane 
fractions enriched in gap junctions allowed us to quantify the 
relative abundance of Cx43 and Cx45 in these preparations, and 
biochemical studies confirmed co-immunoprecipitation of Cx43 
and Cx45. In addition, based on quantitative immunoblotting, we 
report that the magnitude of Cx43 expression in native ventricu-
lar myocardium is ~200 fmol/μg protein, and that Cx43 is ~300 
Figure 6. Sequence of mouse Cx45 (NCBI: X63100). Amino acid residues in black and red bold font indicate the sequence of the C-terminus included 
in the six His-Cx45 CT fusion protein analyzed by mass spectrometry. We obtained 89% coverage of this sequence (red). Seven Ser and one Thr 
residues (highlighted, red underscored) were phosphorylated by CaMKII in vitro as identified by tandem mass spectrometry. Spectra and tables of 
 fragmentation ions are given in the Supplemental Content.
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Materials and Methods
Animals were handled in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals. The Washington University 
Animal Studies Committee approved all protocols used in the 
present study.
Cx45 transgenic mice. Cx45 overexpressing mice. Wild-type 
(WT) and transgenic mice (C57BL6 strain) with cardiac-selec-
tive overexpression of Cx45 (Cx45OEs) were maintained in a 
standard barrier facility. Genotyping and characterization of 
these mice have been reported previously in reference 20.
Cx45 knockout mice. Embryos with genetic ablation of Cx45 
were obtained after timed matings (10.5 days after visualization 
of a vaginal plug) of Cx45+/- mice.13 Uteruses were removed from 
anesthetized mice. The yolk sac was used for PCR genotyping of 
each individual embryo according to previously published pro-
tocols.37 Embryos were homogenized separately for individual 
immunoblot analysis.
Cardiac Cx45-deficient mice. Cx45 floxed mice37 were bred 
with α-myosin heavy chain (MHC)-Cre+ mice38 to create car-
diac-restricted ablation of Cx45. Two polymerase chain reactions 
(PCR) were run for each sample of DNA using the following 
primers to assess for presence of Cx45 floxed alleles:
I3Frev 5'-CTC TAG GAA CAC TGT AAC CTG AGA TGT 
CCC-3'
I5FCfor 5'-GGA TTA AAG GCA TGT GTC ACC ACT 
CTT GGC-3'
IE3rev 5'-AAG AAC GGC CAC AAC TCT GGT AAC AGG 
AAG-3'
and the following primers to assess for presence of the Cre 
recombinase gene:
MHC-Cre, forward 5'-ATG ACA GAC AGA TCC CTC 
CTA TCT CC-3'
MHC-Cre, reverse 5'-CTC ATC ACT CGT TGC ATC 
GAC-3'
Results from mice (FVB strain) of the following three  genotypes 
were pooled and used as controls for the cardiac Cx45-deficient 
(Cre+;Cx45fl/fl) mice: Cre-;Cx45+/+, Cre+;Cx45fl/+, Cre-;Cx45fl/fl.
Cx40 knockin Cx45 atria. Atrial tissue samples from Cx40 
knockin Cx45 mice (Cx40KICx45/KICx45) 39 were obtained from Dr. 
Patrick Jay with the generous permission of Dr. Daniel Gros. 
These atrial samples which lack expression of Cx40 and exhibit 
expression of Cx45 (knocked into the Cx40 locus) served as nega-
tive controls for Cx40 expression and positive controls for Cx45 
expression.
Gap junction-enriched membrane preparations. Gap junc-
tion-enriched membrane fractions were prepared using a pro-
cedure published by Kensler and Goodenough40 using sucrose 
density centrifugation as described in detail in the Supplemental 
Content. The final yield of the gap junction-enriched fraction 
was 3–9 μg protein per g of heart (wet weight).
Quantitative immunoblot analysis. Six His-Cx45 carboxyl-
terminal (CT) and glutathione S-transferase (GST)-Cx43 CT 
fusion protein constructs were grown and purified as described in 
detail in the Supplemental Content. Ventricular homogenates, 
six His-Cx45 CT fusion protein and GST-Cx43 CT fusion 
connexin remodeling in heteromeric gap junctions in health and 
disease are incompletely understood. Post-translational modifica-
tion, specifically phosphorylation, is known to regulate connexin 
function and turnover. Phosphorylation of Cx45 has been shown 
to stabilize Cx45,49 and to increase or decrease junctional conduc-
tance.61 However, little is known about the signaling pathways that 
may be involved in phosphorylation of Cx45. Our data (Fig. 6 and 
Figs. S6–S10 and Tables S5–S9) are the first to identify, by mass 
spectrometry, residues phosphorylated by the multifunctional 
protein kinase, CaMKII. Importantly, activation of CaMKII has 
been shown to play a role in development of cardiac hypertrophy, 
heart failure, myocardial ischemia and infarction.62-66 Several of 
the residues phosphorylated by CaMKII were also phosphorylated 
by CK1 (Figs. S11–S14 and Tables S10–S13). Future studies will 
be required to determine whether CaMKII or CK1 phosphorylates 
Cx45 in vivo and whether this phosphorylation is altered in cardiac 
disease states to an extent that can influence cell-to-cell electrical 
coupling and propagation of action potentials.
Limitations of the study. Although our data indicate that 
Cx45 and Cx43 coexist in native ventricular gap junctions in the 
relative proportions reported, our data do not allow us to dis-
tinguish between heteromeric and heterotypic channels. Based 
on the large sizes of the gap junctions identified and quantified 
in the present study, we suggest that they likely originated from 
myocytes; however, we cannot rule out the possibility that at least 
a fraction of the observed Cx45 signal may be attributed to oth r 
cell types. Nor have we assessed the relative contribution of Cx45 
and Cx43 to gap junction intercellular communication in ven-
tricular myocytes. Furthermore, we have not yet determined the 
physiological relevance of phosphorylation of Cx45 at the spe-
cific residues reported in this study, and whether phosphorylation 
may regulate assembly or function of heteromeric gap junction 
channels in vivo. Our data show that global measures of acti-
vation and conduction are not altered in Cx45OE hearts; thus, 
we have yet to establish a mechanism for increased arrhythmia 
susceptibility in Cx45OEs. The role of Cx45 in the proximal or 
distal conduction system has not been investigated in sufficient 
detail to know whether alterations in the expression level of Cx45 
alone, or superimposed on a background of remodeled Cx43 in 
diseased hearts, may be pathophysiologically relevant in mice or 
in man. Finally, although it appears that an 85% reduction in 
Cx45 in Cre+;Cx45fl/fl mice has modest effects on viability and 
cardiac function, the Cre-lox transgenic mouse produced in the 
present study did not result in total ablation of Cx45 (Figs. 4 
and 5). There are two major hypotheses that may explain the 
selection of surviving Cre+;Cx45fl/fl mice. First, expression of the 
α-MHC promoter may be delayed (even by only one to a few 
hours) in those mice that survive, such that deletion of Cx45 may 
be delayed until after the time when its expression is essential for 
development and viability. Survival of viable lines from individ-
ual founders suggests that delayed expression of the α-MHC pro-
moter may be heritable (perhaps due to epigenetic effects), and 
thus persists in subsequent generations. Alternatively, survival 
of Cre+;Cx45fl/fl mice may reflect only partial ablation of Cx45, 
whereby either a threshold level of Cx45 or a certain number of 




in vitro phosphorylation using either Ca2+/ calmodulin-dependent 
kinase II (CaMKII, New England Biolabs) or casein kinase 1 
(CK1, New England Biolabs) per the manufacturer’s instruc-
tions, and subjected to tandem mass spectrometry using a 
Thermo LTQ XL Orbitrap (Thermo Fisher, San Jose, CA) as 
described previously in reference 45.
Statistical analysis. All values are expressed as mean ± SD. 
Two group comparisons were made using Student’s t-test for 
grouped data. A value of p < 0.05 was considered significant.
Conclusions
The data presented here using a newly derived, fully character-
ized polyclonal anti-Cx45 antibody corroborates previous reports 
of expression of the minor ventricular connexin, Cx45, by work-
ing ventricular myocytes.13,16-19,30-33 We have determined that 
the levels of Cx45 are 0.3% of those of Cx43, and that cardiac-
restricted genetic downregulation or overexpression of Cx45 
does not result in any notable deficits in electrical conduction 
throughout the heart under disease-free conditions. It is possible 
that downregulation of Cx43 with concomitant upregulation of 
Cx45 could shift the relative stoichiometry of these two connex-
ins within heteromeric gap junctions in remodeled ischemic or 
failing hearts. Finally, the role of CaMKII in regulating cardiac 
Cx45 under both normal and pathophysiologic conditions merits 
further investigation.
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protein were each run in different lanes. Three separate Cx45 
CT and three separate Cx43 CT fusion protein preparations were 
used in the quantitative immunoblots reported here (Fig. S1).
Ventricular homogenates from a total of 16 hearts were run 
on nine separate gels as described in the Supplemental Content 
for quantitative immunoblot analysis. Standard fusion protein 
curves were calculated in Excel and the ng of connexin protein 
per 15 μg protein loaded in each lane were converted to fmol/μg 
of total protein.
Immunoprecipitations. We performed co-immunoprecipi-
tation experiments on murine ventricles that were flash frozen, 
pulverized, homogenized and lysed as described in detail in the 
Supplemental Content using monoclonal anti-Cx45 or anti-
Cx43 antibody bound to protein G sepharose. A nonspecific 
IgG1 was used as a negative control.
Immunogold electron microscopy. Ventricular tissue sam-
ples, cut with a vibratome, and isolated gap junction-enriched 
membrane preparations were stained using a pre-embedding pro-
cedure published previously in references 41 and 42 as described 
in the Supplemental Content.
Immunostaining and confocal analysis. Ten-μm frozen sec-
tions were incubated in rabbit anti-Cx45, rabbit anti-Cx43 or goat 
anti-Cx40 antibodies and analyzed on a Zeiss LSM-510 META 
confocal microscope as described in detail in the Supplemental 
Content. A total of five Cre+;Cx45fl/fl and eight control hearts were 
stained in four experiments. Adjacent tissue sections were stain d 
with anti-Cx45, anti-Cx43, anti-Cx40 and secondary (alone) anti-
bodies for each experiment. Confocal images for a given antibody 
and experiment were acquired on the same day with identical 
confocal microscope settings. An investigator blinded to genotype 
quantified immunoreactive signal using ImageJ software. Gap 
junction staining was defined as five or more contiguous pixels.
Anti-Cx45 polyclonal antibody production. The same six 
His-Cx45 CT fusion protein used in the quantitative immu-
noblots was used as antigen to immunize rabbits for production 
of anti-Cx45 antiserum at Pocono Rabbit Farm & Laboratory; 
antiserum was affinity purified and characterized as described in 
detail in the Supplemental Content (Fig. S2).
In vitro electrophysiology studies of cardiac Cx45 trans-
genic mice. C57BL6 WT (n = 6) and Cx45OEs (n = 4) were 
anesthetized with Avertin (0.1 mg/kg) followed by removal 
and retrograde perfusion of hearts via the aorta at 25°C43 for in 
vitro electrophysiology studies and optical mapping as described 
in detail in the Supplemental Content. Inhomogeneity indi-
ces were calculated as described by Lammers et al.44 and in the 
Supplemental Content.
A total of 11 FVB controls and four cardiac Cx45-deficient 
Cre+;Cx45fl/fl mice were subjected to limited electrophysiologi-
cal testing in vitro as described in the Supplemental Content. 
Surface ECGs were recorded from nine mice (n = 5 controls 
and n = 4 Cx45-deficient). Optical maps were obtained from 
five mice (n = 3 controls and n = 2 Cx45-deficient). Activation 
times were measured in 10 mice (n = 8 controls and n = 2 
Cx45-deficient).
High-resolution mass spectrometric identification of Cx45 
phosphorylation sites. Cx45 CT fusion protein was subjected to 
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